Exp Physiol 108:1227 Badenoch JB, Rengasamy ER, Watson C, Jansen K, Chakraborty S, Sundaram RD, Hafeez D, Burchill E, Saini A, Thomas L, Cross B, Hunt CK, Conti I, Ralovska S, Hussain Z, Butler M, Pollak TA, Koychev I, Michael BD, Holling H, Nicholson TR, Rogers JP, Rooney AG (2022) Persistent neuropsychiatric symptoms after Covid-19: a systematic review and meta-analysis
"Currently 400mcg a day but I slowly tapered up from 100mcg a day to what Im on now over the course of a couple months," he wrote
Use of GLP-1s in psychiatry has great potential to mitigate the weight gain and adverse metabolic effects associated with antipsychotic drug treatments, and even address addiction/substance use disorder and possibly other conditions as well
L., Greene, R